Lucas Silva Franco (Lucas S Franco)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Infectious Diseases

Top Venues

Pharmaceuticals (Basel, Switzerland)

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Eduardo Reina, Lucas Silva Franco, Teiliane Rodrigues Carneiro, Eliezer Jesus Barreiro, Lidia Moreira Lima
Stereochemical insights into β-amino- N -acylhydrazones and their impact on DPP-4 inhibition. RSC advances 14 (10) (2024)
Eduardo Reina, Lucas Silva Franco, Teiliane Rodrigues Carneiro, Eliezer Jesus Barreiro, Lidia Moreira Lima
Stereochemical insights into β-amino- N -acylhydrazones and their impact on DPP-4 inhibition. RSC advances 14 (10) (2024)
Lucas Silva Franco, Bárbara da Silva Mascarenhas de Jesus, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga
Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead? Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Lucas Silva Franco, Bárbara da Silva Mascarenhas de Jesus, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga
Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead? Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Carlos Alberto Manssour Fraga
The Magic Methyl and Its Tricks in Drug Discovery and Development. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Lucas Silva Franco, Rodolfo C Maia, Eliezer Jesus Barreiro
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore model. RSC medicinal chemistry 12 (1) (2020)